Tandem Diabetes Care TNDM Debt Issuance Cost Amortization
Debt Issuance Cost Amortization at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's debt issuance cost amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's debt issuance cost amortization?
- Tandem Diabetes Care (TNDM) reported debt issuance cost amortization of $576K in Q1 2026.
- How has Tandem Diabetes Care's debt issuance cost amortization changed year-over-year?
- Tandem Diabetes Care's debt issuance cost amortization increased by 14.1% year-over-year, from $505K to $576K.
- What is the long-term trend for Tandem Diabetes Care's debt issuance cost amortization?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's debt issuance cost amortization has grown at a 1.9% compound annual growth rate (CAGR), from $1.73M to $1.86M.
- What does debt issuance cost amortization mean?
- Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).